Biomarkers of ovarian reserve in childhood and adolescence: A systematic review

Abstract

Introduction Certain medical disorders as well as their management may affect gonadal function. Recent advances in the management of these conditions accompanied by the availability and success of methods of fertility preservation has highlighted the need for assessment of ovarian reserve in childhood and adolescence. Serum anti‐Mullerian hormone (AMH) and antral follicle count are well established markers of ovarian reserve and serum inhibin has also been used. However, literature on reference ranges for ovarian reserve markers in this age‐group is relatively scarce. Thus, our aim was to evaluate published data to estimate reference values of ovarian reserve makers in childhood and adolescence. Material and methods We performed a systematic review of the literature reporting ovarian reserve markers in childhood and adolescence. We included only those studies examining markers of ovarian reserve in the normal healthy population between the ages of 0 and 19 years. PROSPERO registration: CRD42018119064. Results Serum AMH emerged as the most common biomarker assessed. Serum AMH was detectable at birth and, after a transient increase in infancy, increased steadily in childhood. Following a slight decrease at puberty, levels were constant throughout adolescence with a peak in adolescence or early adulthood. The mean serum AMH values during infancy, childhood and adolescence were 10.55, 22.32 and 31.84 pmol/L, respectively. The corresponding median values were 9.85, 24.49 and 26.32 pmol/L. It was not possible to construct age‐specific reference intervals because of methodological heterogeneity, variations in the assay used to measure AMH and differing interval width for age used in included studies. Serum inhibin showed an increase from childhood to adolescence, with median serum inhibin values of 53.86 pg/mL in adolescence. Antral follicle count showed a significant positive correlation with serum AMH and a median value of 30.52 in adolescence. Conclusions We summarize the trends and levels of biomarkers of ovarian reserve from birth until young adulthood. Peak levels of serum AMH are reported in adolescence or early adulthood. We have reported median/mean values for serum AMH in different age‐groups based on data pooled from several studies, which may be used as a reference when evaluating ovarian reserve in childhood and adolescence especially when considering fertility preservation.

Novel Insights Into Monogenic Obesity Syndrome Due to INPP5E Gene Variant: A Case Report of a Female Patient

“…Levels of gonadotropins were within the normal levels, with LH/FSH ratio of 3:1, no clinical or biochemical indicators of hyperandrogenism were found. AMH was below average according to her age and pubertal stage ( 15 ). Previously described individuals with MORMS ( 13 ) had normal growth parameters.…”

Standardizing the surgical management of benign ovarian tumors in children and adolescents: A best practice Delphi consensus statement

“…If the patient has been discharged from surgical follow‐up before they reach this age, the general practitioner (family doctor, GP) needs to be informed at the point of hospital discharge from surgical follow‐up to ensure a timely referral is made. In prepubertal female children, a formal fertility assessment with blood tests and internal US (antral follicle count) is not considered helpful 37,38 …”

“…In prepubertal female children, a formal fertility assessment with blood tests and internal US (antral follicle count) is not considered helpful. 37,38…”

Abnormal Uterine Bleeding in Adolescents and COVID-19: Etiology and Pathogenesis

“…К 14 годам овуляторные циклы регистрируются лишь у 1/3 девочек. Зрелый тип функционирования формируется постепенно, от менархе до 18 лет с постепенным увеличением овуляторных циклов [17,18]. Органическая патология (PALM) выявляется у 10% девочек-подростков [9,19] Основные нарушения менструального цикла и потенциальные причины, связанные с пандемией COVID-19, подразделяют на гипоталамо-гипофизарные, яичниковые и эндометриальные.…”